Following the inhibition of respiratory depression with the administration of SR-141716, a CB1R inverse agonist, it was concluded that the depressive effect was a CB1R mediated mechanism (Pfitzer et al., 2004). The gene discussed is CNR1; the disease is respiratory depression.